Table 2.
Comparison of groups reporting high and low FoR among the active surveillance patients.
| Variable | High FoR (n = 39) |
Low FoR (n = 66) |
p value |
|---|---|---|---|
| Mean age at survey, yr (SD) | 63.7 (4.2) | 65.8 (4.3) | 0.016 |
| Mean follow-up time, yr (SD) | 3.5 (1.5) | 3.9 (1.8) | 0.23 |
| Body mass index class, n (%) | 0.08 | ||
| <25 kg/m2 | 16 (41) | 18 (27) | |
| 25–30 kg/m2 | 21 (54) | 35 (53) | |
| =30 kg/m2 | 2 (5) | 13 (20) | |
| PSA at diagnosis, n (%) | 0.53 | ||
| <10 µg/l | 36 (92) | 57 (86) | |
| =10 µg/l | 3 (8) | 9 (14) | |
| Clinical T stage, n (%) | N/A | ||
| cT1–T2c | 39 (100) | 66 (100) | |
| =cT3a | 0 | 0 | |
| Gleason score at biopsy, n (%) | 0.60 | ||
| 6 | 26 (67) | 50 (76) | |
| 7a | 12 (31) | 15 (23) | |
| =7b | 1 (3) | 1 (1) | |
| EAU risk group, n (%) | 0.49 | ||
| Low risk | 24 (62) | 45 (68) | |
| Intermediate risk | 15 (38) | 21 (32) | |
| High risk | 0 (0) | 0 (0) | |
| Self-rated health, mean (SD) | 75.2 (16.0) | 84.2 (10.4) | 0.001 |
| Incontinence score, mean (SD) | 87.3 (14.4) | 92.4 (10.8) | 0.041 |
| Sexual domain, mean (SD) | 64.6 (25.4) | 70.5 (24.2) | 0.24 |
| Total fatigue score, mean (SD) | 12.9 (4.0) | 10.6 (2.8) | 0.002 |
| Current sleep problems, n (%) | 15 (39) | 12 (18) | 0.022 |
| Hazardous alcohol consumption, n (%) | 8 (21) | 7 (11) | 0.17 |
| Type D personality, n (%) | 8 (21) | 3 (5) | 0.018 |
FoR = fear of recurrence; EAU = European Association of Urology; N/A = Not applicable; SD = standard deviation.